EdgarLookup

Sylvamo Corp — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that Sylvamo Corp filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
3.9%
Profit Margin
Net income ÷ revenue
4.8%
Return on Assets
Net income ÷ assets
-11.2%
Revenue Growth
Year over year

Revenue

Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $3.35B Feb 20, 2026
FY2025 Dec 31, 2024 $3.77B Feb 20, 2026
FY2025 Dec 31, 2023 $3.72B Feb 20, 2026
FY2024 Dec 31, 2022 $3.63B Feb 20, 2025
FY2023 Dec 31, 2021 $2.83B Feb 21, 2024
FY2022 Dec 31, 2020 $2.39B Feb 22, 2023
FY2021 Dec 31, 2019 $4.02B Mar 2, 2022

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $132.00M Feb 20, 2026
FY2025 Dec 31, 2024 $302.00M Feb 20, 2026
FY2025 Dec 31, 2023 $253.00M Feb 20, 2026
FY2024 Dec 31, 2022 $118.00M Feb 20, 2025
FY2023 Dec 31, 2021 $331.00M Feb 21, 2024
FY2022 Dec 31, 2020 $170.00M Feb 22, 2023
FY2021 Dec 31, 2019 $377.00M Mar 2, 2022

Operating Income

Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $251.00M Feb 20, 2026
FY2025 Dec 31, 2024 $453.00M Feb 20, 2026
FY2025 Dec 31, 2023 $441.00M Feb 20, 2026
FY2024 Dec 31, 2022 $553.00M Feb 20, 2025

SG&A Expense

Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $281.00M Feb 20, 2026
FY2025 Dec 31, 2024 $311.00M Feb 20, 2026
FY2025 Dec 31, 2023 $343.00M Feb 20, 2026
FY2024 Dec 31, 2022 $325.00M Feb 20, 2025
FY2023 Dec 31, 2021 $207.00M Feb 21, 2024
FY2022 Dec 31, 2020 $202.00M Feb 22, 2023
FY2021 Dec 31, 2019 $262.00M Mar 2, 2022

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $268.00M Feb 20, 2026
FY2025 Dec 31, 2024 $469.00M Feb 20, 2026
FY2025 Dec 31, 2023 $504.00M Feb 20, 2026
FY2024 Dec 31, 2022 $438.00M Feb 20, 2025
FY2023 Dec 31, 2021 $549.00M Feb 21, 2024
FY2022 Dec 31, 2020 $359.00M Feb 22, 2023
FY2021 Dec 31, 2019 $524.00M Mar 2, 2022

Capital Expenditures (Capex)

Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.

Fiscal Year Period End Value Filed
FY2022 Dec 31, 2022 $149.00M Feb 22, 2023
FY2022 Dec 31, 2021 $69.00M Feb 22, 2023
FY2022 Dec 31, 2020 $66.00M Feb 22, 2023
FY2021 Dec 31, 2019 $118.00M Mar 2, 2022

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $2.76B Feb 20, 2026
FY2025 Dec 31, 2024 $2.60B Feb 20, 2026
FY2024 Dec 31, 2023 $2.87B Feb 20, 2025
FY2023 Dec 31, 2022 $2.71B Feb 21, 2024
FY2022 Dec 31, 2021 $2.60B Feb 22, 2023
FY2021 Dec 31, 2020 $2.91B Mar 2, 2022

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $966.00M Feb 20, 2026
FY2025 Dec 31, 2024 $847.00M Feb 20, 2026
FY2025 Dec 31, 2023 $901.00M Feb 20, 2026
FY2025 Dec 31, 2022 $678.00M Feb 20, 2026
FY2024 Dec 31, 2021 $182.00M Feb 20, 2025
FY2023 Dec 31, 2020 $2.11B Feb 21, 2024
FY2022 Dec 31, 2019 $2.52B Feb 22, 2023
FY2021 Dec 31, 2018 $2.53B Mar 2, 2022

Goodwill

An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $114.00M Feb 20, 2026
FY2025 Dec 31, 2024 $111.00M Feb 20, 2026
FY2025 Dec 31, 2023 $139.00M Feb 20, 2026
FY2024 Dec 31, 2022 $128.00M Feb 20, 2025
FY2023 Dec 31, 2021 $122.00M Feb 21, 2024
FY2022 Dec 31, 2020 $133.00M Feb 22, 2023
FY2021 Dec 31, 2019 $179.00M Mar 2, 2022

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $2.51B Feb 20, 2026
FY2025 Dec 31, 2024 $2.46B Feb 20, 2026
FY2024 Dec 31, 2023 $2.22B Feb 20, 2025
FY2023 Dec 31, 2022 $2.03B Feb 21, 2024
FY2022 Dec 31, 2021 $1.94B Feb 22, 2023
FY2021 Dec 31, 2020 $0 Mar 2, 2022

Long-Term Debt

Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.

Fiscal Year Period End Value Filed
FY2023 Sep 30, 2021 $1.50B Feb 21, 2024

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 3 Feb 20, 2026
FY2025 Dec 31, 2024 7 Feb 20, 2026
FY2025 Dec 31, 2023 6 Feb 20, 2026
FY2024 Dec 31, 2022 2 Feb 20, 2025
FY2023 Dec 31, 2021 7 Feb 21, 2024
FY2022 Dec 31, 2020 3 Feb 22, 2023
FY2021 Dec 31, 2019 8 Mar 2, 2022

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 3 Feb 20, 2026
FY2025 Dec 31, 2024 7 Feb 20, 2026
FY2025 Dec 31, 2023 5 Feb 20, 2026
FY2024 Dec 31, 2022 2 Feb 20, 2025
FY2023 Dec 31, 2021 7 Feb 21, 2024
FY2022 Dec 31, 2020 3 Feb 22, 2023
FY2021 Dec 31, 2019 8 Mar 2, 2022

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 39.40M Feb 20, 2026
FY2025 Dec 31, 2024 40.60M Feb 20, 2026
FY2024 Dec 31, 2023 41.20M Feb 20, 2025
FY2023 Dec 31, 2022 42.60M Feb 21, 2024
FY2022 Dec 31, 2021 43.90M Feb 22, 2023
FY2023 Oct 1, 2021 43.95M Feb 21, 2024